Biological properties of transition-metal organometallic compounds. 3. beta-Ferrocenylalanine.
D000409:Alanine / Q000031:analogs & derivatives / Q000494:pharmacology; D000596:Amino Acids; D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D005296:Ferrous Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D007668:Kidney / Q000201:enzymology; D007934:Leuconostoc / Q000187:drug effects / Q000254:growth & development; D008099:Liver / Q000201:enzymology; D000075163:Metallocenes; D009942:Organometallic Compounds / Q000494:pharmacology*; D010649:Phenylalanine; D010651:Phenylalanine Hydroxylase / Q000037:antagonists & inhibitors; D051381:Rats; D013552:Swine
D000596:Amino Acids; D005296:Ferrous Compounds; D000075163:Metallocenes; D009942:Organometallic Compounds; D010649:Phenylalanine; C019385:beta-ferrocenylalanine; D010651:Phenylalanine Hydroxylase; D002262:Carboxy-Lyases; D000409:Alanine